Introduction
Introduction
The idea barely existed five years ago, but it certainly does now. Digital healthcare technology has arrived—and it’s getting plenty of attention. In a year when US venture capital funding hit its highest point since 2001, with .3 billion, healthcare funding in 2014 dominated the technology space.
In Google's Ambitions in Health, FirstWord maps the journey of one of the leading technology companies and provides context and insights about other companies also investing in the rapidly evolving field of healthcare technology.
Based on expert interviews, market analysis and up-to-date news and views from the field, the report tracks current moves and strategies of leading healthcare tech giants. Focused on Google, and including insights on Apple, Microsoft and others, this report analyses key partnerships and offers insight into pharma’s future in one of the most dynamic and fast-evolving industries.
As digital healthcare technology finds new and innovative ways to put healthcare into the hands of consumers, key questions remain: what might pharma lose by not getting involved in health technology, and where does pharma go from here?
Puchase Reasons
Key Takeaways
Answers to Pressing Questions
Report Features
Expert Contributors
About FirstWord Reports
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
Learn more at www.firstwordgroup.com.
Table of Contents
for Google’s Ambitions in Health
1.Executive summary
2.Methodology and objectives
3.Digital health tech is booming
3.1.Venture capital funding and healthcare IPOs
3.2..1 billion in US digital health funding
3.3.Digital health funding in Europe
3.4.Map of digital health startups in Europe
4.Tech giants in healthcare
4.1.Is the interest of tech giants in healthcare a fad or long-term trend?
4.2.onsumerisation of healthcare
4.3.DIY Health
4.4.Outside expertise brings opportunities for pharma
4.5.What are the opportunities for pharma from this change?
5.Google Ventures quadruples health investments
5.1.Google Ventures invests in Europe
5.2.Google Ventures portfolio
6.Google Ventures capitalises on health data and analytics
6.1.Flatiron Health: largest Google Ventures investment
6.2.GV companies share valuable data for pharma research
6,3,23andMe inks data deals with Genentech, Pfizer, and more
6.4.Foundation Medicine nets billion deal with Roche
6.5.Google X partners with Biogen Idec in multiple sclerosis
6.6.Data sharing deals with pharma raise privacy concerns
6.7.Open APIs and sharing data
6.8.Are there opportunities for pharma in open APIs and sharing data?
6.9.FDA draft guidance for general wellness or low risk devices
7.Google Calico: a separate life sciences company
7.1.Google X Life Sciences Division separate from Calico
7.2.Calico’s partnership with AbbVie
7.3.What are the thoughts on the research Google is doing in life sciences with
7.4.Calico, and its partnership with AbbVie?
8.Google Glass and other health interests
8.1.Google looks to innovate without a concern for profits in the near term.
8.2.Will this be disruptive to pharma?
8.3.Going fast and going slow: speed of innovation
8.4.The tech industry is known for its speed of innovation, and pharma is
traditionally slow. What are the challenges in partnering?
9.Apple’s health app and the HealthKit platform
9.1.What opportunities do you see from Apple HealthKit?
10.Digital Therapeutics: services versus products
10.1.How will new technologies help pharma provide services as opposed to products?
10.2D.o you see pharma developing Digital Therapeutics?
11. Co-creating the future of health
11.1.The keys to building successful partnerships
11.2.A successful alliance: Salesforce and Philips
11.3.Patients at the centre
11.4.What are the keys for a successful partnership between pharma and
technology companies?
11.5.How do you envision the pharma model changing?
12.Conclusion
Additional Details
Publisher
FirstWord Pharma
Publisher Information
Reference
186 |
Report Format
Related Reports
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Ordering Information
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.